Evidence map›Paper›PMID 35664502›Full record

ArticleContemporary clinical trials communications2022

A biobehavioral intervention to enhance recovery following hematopoietic cell transplantation: Protocol for a feasibility and acceptability randomized control trial.

Andrew Kirvin-Quamme, Meredith E Rumble, Lisa Cadmus-Bertram, Mark B Juckett, Paul J Rathouz, Gwynneth Schell, Natalie S Callander, Peiman Hematti, Erin S Costanzo

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Andrew Kirvin-QuammeDepartment of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States.
Meredith E RumbleDepartment of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States.
Lisa Cadmus-BertramPaul P. Carbone Cancer Center, Madison, WI, United States.
Mark B JuckettDivision of Hematology, Oncology, Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
Paul J RathouzDepartment of Population Heath, Dell Medical School, University of Texas at Austin, Austin, TX, United States.
Gwynneth SchellDepartment of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States.
Natalie S CallanderPaul P. Carbone Cancer Center, Madison, WI, United States.
Peiman HemattiPaul P. Carbone Cancer Center, Madison, WI, United States.
Erin S CostanzoDepartment of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States.
University of Wisconsin–Madison · USThe University of Texas at Austin · USUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Insomnia, fatigue, and depression are among the most persistent and distressing concerns for hematologic cancer patients recovering from hematopoietic cell transplantation (HCT). This study will evaluate a novel behavioral intervention, Methods: The protocol herein evaluates the feasibility and acceptability of ReSET by conducting a pilot randomized controlled trial to compare the intervention with usual care. Adults undergoing HCT will be randomly assigned to ReSET or usual care. The ReSET arm will receive 3 face-to-face sessions and telephone coaching delivered in an individual format tailored to each patient. Patient-reported insomnia, fatigue, and depression will be the primary outcome measures. Actigraphy will be used to objectively quantify rest-activity patterns. Semi-structured interviews will evaluate participant satisfaction with ReSET. The goals are to determine: (1) participant satisfaction with and acceptability of the behavioral techniques; (2) facilitator fidelity and participant uptake of key intervention components; (3) ability to recruit, retain, and collect complete data from participants; (4) participant willingness to be randomized and acceptability of the control condition; and (5) validity and acceptability of the assessment strategy. Conclusion: The overarching goal is to optimize recovery following HCT with a brief, non-invasive intervention that can be implemented as a part of routine clinical care.

Indexed as

DepressionFatigueHematopoietic cell transplantation (HCT)InsomniaLeukemiaLymphomaMultiple myeloma

Identifiers

PMID35664502
PMCPMC9160488
OpenAlexW4281696438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.